Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

53.4K
Overview
53.4K
Vaccines01:21

Vaccines

25
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
25
Immunological Memory01:23

Immunological Memory

17.8K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
17.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Strain Agnostic Influenza Virus Propagation in a Serum-Free, Suspension-Adapted MDCK Cell Line.

Influenza and other respiratory viruses·2026
Same author

Validation of prototype virus inactivation from seven virus families of pandemic potential with a novel low-cost, field-deployable RNA extraction and storage method.

Journal of virological methods·2025
Same author

Whole-Thorax Irradiation Induces Persistent T Cell Clonal Dysregulation in Pediatric Rhesus Macaques.

Radiation research·2025
Same author

Nasal immunization with compound 48/80-adjuvanted acellular pertussis vaccines is an effective strategy to induce pertussis-specific systemic and mucosal immunity.

Clinical and experimental vaccine research·2025
Same author

Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primates.

Science translational medicine·2025
Same author

Importance of outbreak response research in bridging knowledge gaps on emerging infectious diseases.

BMJ global health·2025

Related Experiment Video

Updated: Mar 21, 2026

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

13.5K

Modified Vaccinia Ankara Virus Vaccination Provides Long-Term Protection against Nasal Rabbitpox Virus Challenge.

Dorothy I Jones1, Charles E McGee2, Christopher J Sample2

  • 1Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.

Clinical and Vaccine Immunology : CVI
|May 6, 2016
PubMed
Summary

Modified vaccinia Ankara virus (MVA) vaccination offers long-term protection against rabbitpox virus challenges. Two MVA doses protected rabbits from lethal intranasal challenge 9 months post-vaccination, demonstrating durable immunity.

More Related Videos

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
13:00

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus

Published on: July 31, 2021

4.2K
Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
09:13

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Published on: November 1, 2011

18.2K

Related Experiment Videos

Last Updated: Mar 21, 2026

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

13.5K
Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
13:00

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus

Published on: July 31, 2021

4.2K
Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
09:13

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Published on: November 1, 2011

18.2K

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Modified vaccinia Ankara virus (MVA) is a highly attenuated strain of vaccinia virus.
  • MVA is a promising candidate for a next-generation smallpox vaccine.
  • Rabbitpox virus (RPXV) serves as a relevant animal model for studying orthopoxvirus infections, including smallpox.

Purpose of the Study:

  • To evaluate the long-term protective efficacy of MVA vaccination against rabbitpox virus (RPXV).
  • To determine if a prime-boost vaccination regimen with MVA confers durable immunity against a lethal orthopoxvirus challenge.

Main Methods:

  • Two doses of MVA were administered to rabbits.
  • Rabbits were challenged intranasally with a lethal dose of RPXV 9 months after the second MVA vaccination.
  • Protection was assessed by monitoring survival rates and clinical signs.

Main Results:

  • Two doses of MVA conferred 100% protection against a lethal intranasal RPXV challenge.
  • The protection was observed 9 months after the vaccination, indicating long-term immunity.
  • No mortality or significant morbidity was observed in the vaccinated group post-challenge.

Conclusions:

  • MVA vaccination provides robust and long-lasting protection against orthopoxvirus challenge in a relevant animal model.
  • The MVA vaccine candidate demonstrates potential for sustained immunity, crucial for effective smallpox countermeasures.
  • These findings support the continued development of MVA as a safe and effective vaccine against smallpox and related diseases.